Analgesics received one of the highest demand spikes of any category when lockdown restrictions began to take effect in March. Slovakian consumers had a strong urge to stockpile analgesics and any other products considered essential or that might help mitigate symptoms of COVID-19.
Manufacturers also struggled to cope with the exceptional levels of demand for some products in 2020. Zentiva, the leading company in analgesics by quite a margin, experienced unprecedented demand for its paracetamol and ibuprofen brands in particular, leading to shortages of some products.
Product shortages of the best-known brands at the start of lockdown did provide an opportunity for lower ranked brands, which gained increasing recognition in the temporary absence of bigger players. Despite the dominance of Zentiva, there is strong competition in analgesics.
Even before COVID-19 entered the public consciousness, analgesics were well placed to thrive in Slovakia. Analgesics was one of the most popular OTC categories among Slovak consumers in the review period given widespread use of such products for symptom suppression of common ailments like flu, general body pains, back, joint, muscle and tooth ache.
Adult acetaminophen continues to drive a large proportion of growth within analgesics. Rising sales can mainly be attributed to the strong popularity of the Paralen brand by Zentiva, which is mostly used to treat fever, with sales also being boosted by regular product launches.
Traditionally, Slovak parents have often given adult analgesics to their children when they had flu as they had it at hand in their household ready to use, with popular brands including Paralen, Voltaren, Aspirin and Acylpyrin. Moreover, the low number of specific products intended for children and their significantly higher price compared to adult analgesics resulted in a low sales base for paediatric analgesics.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Analgesics industry in Slovakia with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Slovakia, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page